Grove raised $4.9M in Seed funding led by A* to scale its team and product for clinical trial management.

Jan 09, 2025•11 months ago

Amount Raised

$4.9 Million

San FranciscoMachine LearningArtificial IntelligenceBiotechnologyHealth Care

Investors

Till PieperPhuc TruongChloe YooAjit BaidUpfront VenturesPear VcLife X VenturesAfore CapitalA*

Description

Grove, based in San Francisco, CA, has raised $4.9M in Seed funding to enhance its clinical trial management platform. The funding round was led by A* with participation from several prominent investors. Grove aims to redefine clinical trials into participant-centered ecosystems using real-time data.

Company Information

Company

Grove AI

Location

San Francisco, California, United States

About

Grove AI revolutionizes clinical trials with its AI-powered participant relationship management (PRM) platform, delivering actionable insights and accelerating critical trial processes. Grove empowers research organizations to streamline operations, engage participants, and accelerate life-saving therapies. With Grove, clinical trials shift from cumbersome, manual workflows to adaptive, data-driven ecosystems that operate at the speed of innovation—bringing life-saving treatments to patients faster than ever.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns